| Expression pattern: |
UP |
| Associated gene: |
p-GSK-3beta, GSK-3beta, beta-catenin |
| Associated microRNA: |
- |
| Biological function: |
promotes osteosarcoma cell proliferation and colony formation; promotes chemotherapy resistance (cisplatin resistance) |
| Molecular mechanism: |
activates the Wnt/beta-catenin signaling pathway, accompanied by increased p-GSK-3beta and beta-catenin and decreased GSK-3beta |
| Biological pathway or process: |
Wnt/beta-catenin (promotes); proliferation (promotes); chemoresistance (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Transfection; CCK8; Colony Formation Assay; Western Blot |
| Clinical significance: |
Higher circ_001569 expression significantly correlated with distant metastasis and advanced tumor stage of osteosarcoma patients; correlated with poor prognosis |
| Description: |
circ_001569 is up-regulated in osteosarcoma tissues and cell lines and is associated with distant metastasis and advanced TNM stage. Functionally, circ_001569 promotes osteosarcoma cell proliferation/colony formation and increases cisplatin (and other chemotherapy) resistance by activating the Wnt/beta-catenin signaling pathway. |
| Confidence score: |
0.5358 |